Covered recipient · General Payments record
MARK A RINGLE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2022
$1,369.21
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $176.47 | 12 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $42.12 | 3 |
| Lilly USA, LLC | $38.54 | 3 |
| Novo Nordisk AS | $34.10 | 2 |
| ABBVIE INC. | $31.67 | 2 |
| Daiichi Sankyo Inc. | $15.99 | 1 |
| Amgen Inc. | $14.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.18 | 03/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891454937 | CMS |
| ABBVIE INC. | $15.49 | 04/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891454939 | CMS |
| Amgen Inc. | $14.05 | 03/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939882895 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.55 | 03/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915778509 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.69 | 04/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915129649 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.88 | 06/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 914899567 | CMS |
| Daiichi Sankyo Inc. | $15.99 | 03/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 930810985 | CMS |
| Lilly USA, LLC | $12.54 | 04/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918260761 | CMS |
| Lilly USA, LLC | $11.65 | 04/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918260759 | CMS |
| Lilly USA, LLC | $14.35 | 07/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918260757 | CMS |
| Novo Nordisk Inc | $16.04 | 02/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899666599 | CMS |
| Novo Nordisk Inc | $18.06 | 02/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899274153 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022
- Source files
- Dataset page · Bulk file · PY2020 , PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.